Comparison of Time From Symptom Onset to Oseltamivir Access When Oseltamivir is Prescribed by Pharmacists vs. Physicians and the Impact on Symptoms, Oseltamivir Resistance, and Patient Safety
Phase of Trial: Phase IV
Latest Information Update: 08 Aug 2013
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms ACCESS
- Sponsors Roche
- 19 Apr 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 02 Nov 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.
- 14 Sep 2012 Planned end date changed from 1 May 2012 to 1 May 2013 as reported by ClinicalTrials.gov record.